Skip to main content
NIH funding notice RFA-DK-23-007

Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)

Closed on July 9, 2024.

Posted
April 1, 2024
Close date
July 9, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,535,089 in first-year total cost, median $847,822.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-J (J2)]6

Most frequent institutions

  1. UNIVERSITY OF CHICAGO2
  2. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
  3. UNIVERSITY OF COLORADO DENVER1
  4. UNIVERSITY OF PENNSYLVANIA1
  5. WEILL MEDICAL COLL OF CORNELL UNIV1
Competing awards under RFA-DK-23-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025Interferon Signaling in the T1D Islet Microenvironment2U01DK127786-05EVANS-MOLINA, CARMELLAMIRMIRA, RAGHAVENDRA GNAKAYASU, ERNESTO SATOSHIUNIVERSITY OF CHICAGO, IL$3,546,985ZDK1
2025Beta cell death in early type 1 diabetes caused by innate immune response to inefficient RNA editing1U01DK143477-01KAESTNER, KLAUS HUNIVERSITY OF PENNSYLVANIA, PA$1,786,925ZDK1
2025Role of Pancreatic Elastase in Beta Cell Health, Autoimmunity and Type 1 Diabetes1U01DK143494-01ANDERSON, MARK SKULKARNI, ROHIT N.OAKES, SCOTT A.UNIVERSITY OF CHICAGO, IL$852,465ZDK1
2025Decoding the Cell-specific Impact of Epigenomic and Alternative Splicing Regulation during T1D Progression1U01DK143498-01CHEN, SHUIBINGPARKER, STEPHEN CJWEILL MEDICAL COLL OF CORNELL UNIV, NY$843,179ZDK1
2025Driving next generation UPR inhibitory kinase inhibitors for T1D1U01DK143500-01MALY, DUSTIN JPAPA, FEROZ RUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$816,325ZDK1
2025The Role of Granular Acidification in the Pathogenesis of Type 1 Diabetes1U01DK143495-01DELONG, THOMASUNIVERSITY OF COLORADO DENVER, CO$689,210ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-DK-23-007: Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience